NasdaqGS:OFIXMedical Equipment
Orthofix Medical Q1 Preview Shrinking Losses Test Bullish Profitability Narratives
Orthofix Medical (OFIX) opened 2026 by reporting Q1 results that sit against a recent run of quarterly losses, with Q4 2025 revenue at US$219.9 million and a basic EPS loss of US$0.06 on net income loss of US$2.2 million. The trailing twelve months show revenue of US$822.3 million against a basic EPS loss of US$2.33 and a net income loss of US$92.2 million. Over recent quarters, the company has seen revenue move from US$193.6 million in Q1 2025 to US$219.9 million in Q4 2025, while quarterly...